GlassScriptPhysician profile
Oscar C Wille
NPI 1376738336
$620.30
in general payments reported to CMS, 2019-2025
11 companies · $620 in 2025
The $620 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $212.67 | 2025 | Intracept |
| Abbott Laboratories | $113.56 | 2025 | Proclaim |
| Collegium Pharmaceutical, INC. | $89.24 | 2025 | Belbuca, Nucynta |
| Spr Therapeutics, INC | $40.12 | 2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $36.80 | 2025 | |
| Ibsa Pharma INC. | $31.95 | 2025 | Licart, Flector, Tirosint |
| Spinal Simplicity, LLC | $25.36 | 2025 | Ha Minuteman G3-R |
| Curonix LLC | $20.84 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.16 | 2025 | Relistor |
| Tonix Medicines, INC. | $16.15 | 2025 | Tonmya |
| Valinor Pharma, LLC | $15.45 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Wille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.